| First Author | Tadayon S | Year | 2019 |
| Journal | Sci Immunol | Volume | 4 |
| Issue | 33 | PubMed ID | 30926591 |
| Mgi Jnum | J:373482 | Mgi Id | MGI:8186608 |
| Doi | 10.1126/sciimmunol.aat0297 | Citation | Tadayon S, et al. (2019) Clever-1 contributes to lymphocyte entry into the spleen via the red pulp. Sci Immunol 4(33):eaat0297 |
| abstractText | Lymphocytes recirculate continuously between the blood and lymphoid organs, a process that is of fundamental importance for proper functioning of the immune system. The molecular mechanisms underlying lymphocyte trafficking to the spleen remain an enigma. Here, we show that lymphocytes enter the spleen preferentially from vessels in the red pulp rather than the marginal sinus or the vasculature in the white pulp. Ex vivo adhesion assays in mice and humans, together with genetic ablation of Clever-1 in mice, indicate that CD8(+) T cell and B220(+) B cell homing to the spleen via the red pulp is Clever-1 dependent. Moreover, absence of Clever-1 leads to down-regulation of the B cell attractant chemokine, CXCL13, on spleen endothelium. CXCL13 is known to guide B cell trafficking to lymphoid organs, and its lack may contribute to the observed decrease in B cell trafficking into the spleen as well. In summary, this study identifies Clever-1 as an important molecule controlling lymphocyte entry into the spleen, along with a critical role for the splenic red pulp in this regulated trafficking. Furthermore, the results demonstrate that location-specific homing-associated molecules guide lymphocyte entry into the spleen. |
